23andme glp-1 The Research Institute just published a study of 27,000+ people in Nature today, and found DNA can influence how you respond to medications. If you want to learn more about Genetics Could Decide Who Wins

In the months since we launched the GLP-1 Supply Tracker, theres been news and updates about the GLP-1 shortages

Struggling with PCOS

In this piece, I share why most GLP-1 contracts reward the wrong outcome, the three commercial models that dominate this market, and where each one has an opportunity to improve, and how Twin built a commercial model that finally puts the vendor's incentives on the same side as yours.

An HMH specialist explains the risks.

Low-income Californians who use Wegovy and similar medications for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead